characteristics.text: SAMN31788647
characteristics.characteristic: External Id
characteristics.text: University of Cambridge
characteristics.characteristic: INSDC center name
characteristics.text: 2024-02-14T00:50:13.670Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-02-14T00:50:13.670Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS15800382
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS15800382
characteristics.characteristic: SRA accession
characteristics.text: 4 years
characteristics.characteristic: age
characteristics.text: Suzanne Turner
characteristics.characteristic: biomaterial_provider
characteristics.text: SHSY5Y
characteristics.characteristic: cell_line
characteristics.text: SHSY5Y after CRISPR Knock out and treatment for 14 days with the respective compound (specified in sample name)
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Bone marrow-Neuroblastoma
characteristics.characteristic: tissue
characteristics.text: Ceritinib 750nM 1-Lane2
characteristics.characteristic: title
characteristics.text: Ceritinib 750nM 1-Lane2
characteristics.characteristic: treatment